Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy

Cancer Immunology, Immunotherapy

Volumn 56, Issue 5, 2007, Pages 649-658

  Stott, Brandon ^a   Korbelik, Mladen ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Complement gene expression; Heat shock protein 70; Mouse tumor model; Photodynamic therapy of cancer; Toll like receptors 2 and 4; Tumor associated macrophages

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C9; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOTOFRIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; GENE EXPRESSION; LIVER; LUNG CARCINOMA; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION; UPREGULATION;

ANIMALS; CARCINOMA, LEWIS LUNG; COMPLEMENT C3; COMPLEMENT C5; COMPLEMENT C9; DIHEMATOPORPHYRIN ETHER; GENE EXPRESSION; GENE EXPRESSION PROFILING; HSP70 HEAT-SHOCK PROTEINS; MACROPHAGES; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 33847418810     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-006-0221-z     Document Type: Article

References (34)

1. Akira A, Takeda K (2004) Toll-like receptor signaling. Nat Rev Immunol 4:499-511
2. Alper CA, Johnson AM, Birtch AG, Moore FD (1969) Human C3: evidence for the liver as the primary site of synthesis. Science 163:286-288
3. Bihl F, Lariviere L, Quereshi ST, Flaherty L, Malo D (2001) LPS-hyporesponsiveness of mnd mice is associated with a mutation in Toll-like receptor 4. Genes Immun 2:56-59
4. Canti G, De Simone A, Korbelik M (2002) Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 1:79-80
5. Cecic I, Korbelik M (2002) Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett 183:43-51
6. Cecic I, Serrano K, Gyongyossy-Issa M, Korbelik M (2005) Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy. Cancer Lett 225:215-223
7. Cecic I, Korbelik M (2006) Deposition of complement proteins on cells treated by photodynamic therapy in vitro. J Environ Pathol Toxicol Oncol 25:189-203
8. Cecic I, Sun J, Korbelik M (2006) Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells. Photochem Photobiol 82:558-562
9. Cecic I, Stott B, Korbelik M (2006) Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol 6:1259-1266
10. Chen WR, Adams RL, Higgins AK, Bartels KE, Nordquist RE (1966) Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study. Cancer Lett 98:169-173
11. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889-905
12. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
13. Gollnick SO, Liu X, Owczarczak B, Musser DA, Henderson BW (1997) Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57:3904-3909
14. Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55:145-157
15. Huang Z (2005) A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4:283-294
16. Illing RO, Kennedy JE, Wu F, ter Haar GR, Protheroe AS, Friend PJ, Gleeson FV, Cranston DW, Phillips RR, Middleton MR (2005) The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 93:890-895
17. Ivarsson K, Myllymaki L, Jansner K, Stenram U, Tranberg KG (2005) Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. Br J Cancer 93:435-440
18. Korbelik M, Krosl G (1996) Photofrin accumulation in malignant and host cell populations of various tumours. Br J Cancer 73:506-513
19. Korbelik M, Sun J, Cecic I (2005) Photodynamic therapy-induced cell surface expression and release of heat shock protein: relevance for tumor response. Cancer Res 65:1018-1026
20. Korbelik M, Merchant S, Stott B, Cecic I, Payne P, Sun J (2006) Acute phase response induced following tumor treatment by photodynamic therapy: relevance for the therapy outcome. Proc SPIE 6087:60870C1-60870C7
21. Korbelik M (2006) PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 38:500-508
22. Krosl G, Korbelik M, Dougherty GJ (1995) Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy. Br J Cancer 71:549-555
23. Kuflik EG (2004) Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg 30:297-300
24. Laufer J, Katz Y, Passwell JH (2001) Extrahepatic synthesis of complement proteins in inflammation. Mol Immunol 38:221-229
25. Moore FT, Blackwood J, Sanzenbacher L, Pace WG (1968) Cryotherapy for malignant tumors. Immunologic response. Arch Surg 96:527-529
26. Morgan BP, Gasque P (1997) Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol 107:1-7
27. Morgan BP (2000) The complement system: an overview. In: Morgan BP (ed) Methods in molecular biology, Vol. 150: complement methods and protocols. Humana Press Inc., Totowa, NJ, pp1-13
28. Naughton MA, Botto M, Carter MJ, Alexander GJM, Goldman JM, Walport MJ (1996) Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J Immunol 156:3051-3056
29. Nauta AJ, Roos A, Daha MR (2004) A regulatory role for complement in innate immunity and autoimmunity. Int Arch Allergy Immunol 134:310-323
30. Pareek G, Nakada SY (2005) The current role of cryotherapy for renal and prostate tumors. Urol Oncol 23:361-366
31. Sugiura K, Stock CC (1955) The effect of phosphoramides on the growth of a variety of mouse and rat tumors. Cancer Res 15:38-51
32. Tranberg KG (2004) Percutaneous ablation of liver tumors. Best Pract Res Clin Gastroenterol 18:125-145
33. Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, Jin CB (2004) Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol 30:1217-1222
34. Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, Li KQ, Jin CB, Xie FL, Su HB (2005) Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat 92:51-60